Neuropathic Pain Market Research Reports

Neuropathic Pain Market Research

Neuropathic pain results from damage to or dysfunction of the peripheral or central nervous system, rather than stimulation of pain receptors.

As per research it is estimated that the global neuropathic pain market will reach a value of $4.8 billion in 2008. This market is expected to grow at a Compound Annual Growth Rate (CAGR) of approximately 4.3% from $4.8 billion in 2008 to $6.5 billion in 2015. It is believed that this growth will be supported by the increase in the aging population, increased treatment seeking behavior and increased uptake of the current products. The diagnosis rate remains as one of the barriers for the growth of the market and the available treatment options are moderately successful in meeting the market demand.

The Neuropathic Pain drug therapy market research report provides insight into the pipeline status of neuropathic pain therapeutics by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.

The study basically aims at providing a comprehensive overview of the on-goings of the neuropathic pain drugs market.



 

View More
TITLE Actions
Neuropathic Pain - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Neuropathic Pain - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Neuropathic Pain epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028. ...

Diabetic Neuropathic Pain - Pipeline Insight, 2019
Published in Jan 2019 | US $ 1500 Onwards | By Delve Insight

"Diabetic Neuropathic Pain - Pipeline Insight, 2019” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diabetic Neuropathic Pain development. The report provides ...

Neuropathic  Pain - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Neuropathic Pain - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Neuropathic Pain epidemiology and market outlook for the 7MM. Markets Covered - United States...

Peripheral Neuropathic Pain - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Peripheral Neuropathic Pain - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Peripheral Neuropathic Pain epidemiology, providing the historical and forecasted data for the 7MM during the forecast period f...

Peripheral Neuropathic Pain - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Peripheral Neuropathic Pain - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Peripheral Neuropathic Pain epidemiology and market outlook for the 7MM. Markets Covered...

Peripheral Neuropathic Pain - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
Published in Jan 2019 | US $ 2000 Onwards | By Delve Insight

Introduction DelveInsight's, “Peripheral Neuropathic Pain - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019" report provides comprehensive insights about marketed and Phase III products for Peripheral Neuropathic Pain . ...

Global Neuropathic Pain Drugs Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of ...

Global Diabetic Neuropathic Pain Drug Market Insights, Forecast to 2025
Published in Dec 2018 | US $ 3900 Onwards | By QYResearch Group

In 2017, the global Diabetic Neuropathic Pain Drug market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Diabetic Neuropathi...

Global and Chinese Diabetic Neuropathic Pain Drug Industry, 2018 Market Research Report
Published in Nov 2018 | US $ 3000 Onwards | By Prof Research

The 'Global and Chinese Diabetic Neuropathic Pain Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Diabetic Neuropathic Pain Drug industry with a focus on the Chinese market. The...

Global Diabetic Neuropathic Pain Drug Market Research Report 2018
Published in Oct 2018 | US $ 2900 Onwards | By QYResearch Group

This report studies the global Diabetic Neuropathic Pain Drug market status and forecast, categorizes the global Diabetic Neuropathic Pain Drug market size (value & volume) by manufacturers, type, application, and region. This report ...

Global Neuropathic Pain Drugs Market Size, Status and Forecast 2018-2025
Published in Sep 2018 | US $ 3900 Onwards | By QYResearch Group

This report focuses on the global Neuropathic Pain Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neuropathic Pain Drugs development in United States, Europe and China. ...

Global Diabetic Neuropathic Pain Drug Market Professional Survey Report 2018
Published in Jul 2018 | US $ 3500 Onwards | By QYResearch Group

This report studies the global Diabetic Neuropathic Pain Drug market status and forecast, categorizes the global Diabetic Neuropathic Pain Drug market size (value & volume) by manufacturers, type, application, and region. This report focuses on the t...

Global Diabetic Neuropathic Pain Drug Sales Market Report 2018
Published in Jun 2018 | US $ 4000 Onwards | By QYResearch Group

This report studies the global Diabetic Neuropathic Pain Drug market status and forecast, categorizes the global Diabetic Neuropathic Pain Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top...

Neuropathic Pain - Pipeline Review, H1 2018
Published in Jun 2018 | US $ 2000 Onwards | By Global Markets Direct

Neuropathic Pain - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H1 2018, provides an overview of the Neuropathic Pai...

United States Diabetic Neuropathic Pain Drug Market Report 2018
Published in Jun 2018 | US $ 3800 Onwards | By QYResearch Group

In this report, the United States Diabetic Neuropathic Pain Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, thi...

Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2018
Published in Apr 2018 | US $ 2500 Onwards | By GlobalData

Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, “Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2018" provides an overview of Peripheral Neuropa...

2018-2025 Diabetic Neuropathic Pain Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
Published in Apr 2018 | US $ 3600 Onwards | By QYResearch Group

Summary This report studies the Diabetic Neuropathic Pain Drug market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and...

Neuropathic Pain Global Clinical Trials Review, H1, 2018
Published in Mar 2018 | US $ 2500 Onwards | By GlobalData

Neuropathic Pain Global Clinical Trials Review, H1, 2018 Summary GlobalData's clinical trial report, “Neuropathic Pain Global Clinical Trials Review, H1, 2018" provides an overview of Neuropathic Pain clinical trials scenari...

Neuropathic Pain - Pipeline Review, H2 2017
Published in Dec 2017 | US $ 2000 Onwards | By Global Markets Direct

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H2 2017, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape. Neuropathic pain...

Diabetic Neuropathic Pain Global Clinical Trials Review, H2, 2017
Published in Jul 2017 | US $ 2500 Onwards | By GlobalData

Diabetic Neuropathic Pain Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, “Diabetic Neuropathic Pain Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Neuropathic P...

We are on:

Need Help?